CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 425 enrolled
Drug / intervention
Crystalloid Solutions +5 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04600271
NCT04600271N/ACompleted

Risk Factors of Acute Kidney Injury After Major Elective Non-Cardiac Surgery : A Prospective Observational Study

Istanbul University·observational·Posted Oct 23, 2020·Updated Sep 22, 2021

In Brief

An observational study evaluating Crystalloid Solutions, Colloid Blood Volume Expanders, and 4 other interventions for Acute Renal Injury. Completed, enrolled 425 participants across 1 site.

Detailed Summary

The study is planned to be a single-center study and includes patients who underwent major surgery within Istanbul University Istanbul Faculty of Medicine with an invasive arterial line. Our aim to define the incidence of acute renal injury in our setting and to investigate the risk factors listed in detailed description. After obtaining written informed consent from the patients, preoperative risk factors will be notes. Following standard anesthesia monitoring as well as routine anesthesia induction and maintenance, invasive arterial monitoring will be performed due to the major surgery and hemodynamic values will be recorded throughout the surgery. The primary outcome will be acute renal injury based on KDIGO's (Kidney Disease: Improving Global Outcomes) definition of acute renal damage. Postoperative data regarding this outcome as well as additional data listed in detailed description will be collected.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedOct 23, 2020
Enrollment StartJun 1, 2019
Primary CompletionNov 1, 2020
Study CompletionFeb 1, 2021
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 5.7 years ago

Interventions

Crystalloid Solutionsdrug

exposure

Colloid Blood Volume Expandersdrug

exposure

blood replacementother

exposure

Diureticdrug

exposure

noradrenalinedrug

exposure

Non-Steroidal Anti-Inflammatory Analgesicsdrug

exposure